Advantech Capital L.P. 13D/13G Filings for Sinovac Biotech Ltd. (SVA)

Advantech Capital L.P. 13D and 13G filings for Sinovac Biotech Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-07-14
06:16 am
Unchanged
2025-07-0813DSINOVAC BIOTECH LTD
SVA
Advantech Capital L.P.5,851,423
8.140%
0
(Unchanged)
Filing
2025-04-10
06:12 am
Unchanged
2025-04-0913DSINOVAC BIOTECH LTD
SVA
Advantech Capital L.P.5,851,423
8.140%
0
(Unchanged)
Filing
2025-03-25
10:48 am
Unchanged
2025-03-1813DSINOVAC BIOTECH LTD
SVA
Advantech Capital L.P.5,851,423
8.140%
0
(Unchanged)
Filing
2024-03-20
07:33 am
Sale
2023-12-3113GSINOVAC BIOTECH LTD
SVA
Advantech Capital L.P.5,851,423
8.160%
-48,577decrease
(-0.82%)
Filing